Capgemini has won a new contract to support the innovation and development (I&D) activities at Terumo BCT, a U.S.-based provider of blood component, therapeutic apheresis and cellular technologies.
The partnership will help Terumo BCT set up two global innovation and development (I&D) centers in India.
Capgemini will deliver a multi-disciplinary engagement across research and development, product engineering, and usability engineering, the company said.
The partnership will leverage Capgemini’s expertise in connected healthcare, including the Internet of Things (IoT), and artificial intelligence (AI).
“As technology helps us unlock the potential of blood and cellular therapies, it makes perfect sense for us to collaborate with Capgemini. Their global expertise and best practices from other industries will help us bring about the next-generation of connected medical devices,” said Palani Palaniappan, executive vice president, Innovation and Development, Terumo BCT.
editor@infotechlead.com
